Kalo Musukuma-Chifulo

Ms. Kalo Musukuma-Chifulo

University of Zambia, Lusaka, Zambia
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GWGilles Wandeler
Gilles Wandeler
KMKalo Musukuma-Chifulo
Kalo Musukuma-Chifulo
SZSamuel Zürcher
Samuel Zürcher
MVMichael J. Vinikoor
Michael J. Vinikoor
JLJara Llenas-García
Jara Llenas-García
IAIeDEA-Southern Africa
IeDEA-Southern Africa
Few data on the virological determinants of hepatitis B virus (HBV) infection are available from southern Africa. We enrolled consecutive HIV-infected adult patients initiating antiretroviral therapy (ART) at two urban clinics in Zambia and four rural clinics in Northern Mozambique between May 2013 and August 2014. HBsAg screening was performed using the Determine® rapid test. Quantitative real-time PCR and HBV sequencing were performed in HBsAg-positive patients. Risk factors for HBV infection were evaluated using Chi-square and Mann-Whitney tests and associations between baseline characteristics and high level HBV replication explored in multivariable logistic regression. Seventy-eight of 1,032 participants in Mozambique (7.6%, 95% confidence interval [CI]: 6.1–9.3) and 90 of 797 in Zambia (11.3%, 95% CI: 9.3–13.4) were HBsAg-positive. HBsAg-positive individuals were less likely to be female compared to HBsAg-negative ones (52.3% vs. 66.1%, p20,000 UI/mL). HBsAg-positive individuals had higher levels of ALT and AST compared to HBsAg-negative ones (both p<0.001). In multivariable analyses, male sex (adjusted odds ratio: 2.59, 95% CI: 1.22–5.53) and CD4 cell count below 200/μl (2.58, 1.20–5.54) were associated with high HBV DNA. HBV genotypes A1 (58.8%) and E (38.2%) were most prevalent. Four patients had probable resistance to lamivudine and/or entecavir. One half of HBsAg-positive patients demonstrated high HBV viremia, supporting the early initiation of tenofovir-containing ART in HIV/HBV-coinfected adults.

3 September 2015 in Journal of Clinical Virology
Verified
Journal Article
Closed access
MVMichael J. Vinikoor
Michael J. Vinikoor
SZSamuel Zürcher
Samuel Zürcher
KMKalo Musukuma-Chifulo
Kalo Musukuma-Chifulo
OKObert Kachuwaire
Obert Kachuwaire
ARAndri Rauch
Andri Rauch
GWGilles Wandeler
Gilles Wandeler

1 July 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CCCaroline Cleopatra Chisenga
Caroline Cleopatra Chisenga
SBSamuel Bosomprah
Samuel Bosomprah
KMKalo Musukuma-Chifulo
Kalo Musukuma-Chifulo
CMCynthia Mubanga
Cynthia Mubanga
OCObvious N. Chilyabanyama
Obvious N. Chilyabanyama
RCRoma Chilengi
Roma Chilengi
The re-emergence of vector borne diseases affecting millions of people in recent years has drawn attention to arboviruses globally. Here, we report on the sero-prevalence of chikungunya virus (CHIKV), dengue virus (DENV), mayaro virus (MAYV) and zika virus (ZIKV) in a swamp community in Zambia. We collected blood and saliva samples from residents of Lukanga swamps in 2016 during a mass-cholera vaccination campaign. Over 10,000 residents were vaccinated with two doses of Shanchol™ during this period. The biological samples were collected prior to vaccination (baseline) and at specified time points after vaccination. We tested a total of 214 baseline stored serum samples for IgG antibodies against NS1 of DENV and ZIKV and E2 of CHIKV and MAYV on ELISA. We defined sero-prevalence as the proportion of participants with optical density (OD) values above a defined cut-off value, determined using a finite mixture model. Of the 214 participants, 79 (36.9%; 95% CI 30.5–43.8) were sero-positive for Chikungunya; 23 (10.8%; 95% CI 6.9–15.7) for Zika, 36 (16.8%; 95% CI 12.1–22.5) for Dengue and 42 (19.6%; 95% CI 14.5–25.6) for Mayaro. Older participants were more likely to have Zika virus whilst those involved with fishing activities were at greater risk of contracting Chikungunya virus. Among all the antigens tested, we also found that Chikungunya saliva antibody titres correlated with baseline serum titres (Spearman’s correlation coefficient = 0.222; p = 0.03). Arbovirus transmission is occurring in Zambia. This requires proper screening tools as well as surveillance data to accurately report on disease burden in Zambia.

17 October 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKombatende Sikombe
Kombatende Sikombe
CHCardinal Hantuba
Cardinal Hantuba
KMKalo Musukuma-Chifulo
Kalo Musukuma-Chifulo
ASAnjali Sharma
Anjali Sharma
NPNancy Padian
Nancy Padian
EGElvin Geng
Elvin Geng
Regular plasma HIV-RNA testing for persons living with HIV on antiretroviral therapy (ART) is now the global standard, but as many as 60% of persons in Africa today on ART do not have access to standard laboratory HIV-RNA assays. As a result, patients in Zambia often receive treatment without any means of determining true virologic failure, which poses a risk of premature switch of ART regimens and widespread HIV drug resistance. Dry blood spots (DBS) on the other hand require unskilled personnel and less complex storage supply chain so are ideal to capture viral-load results from HIV patients outside clinic settings. We assess collection of DBS in the community using non-medically trained personnel (NMP) and documented challenges. We trained 23 NMP to collect DBS from lost to follow-up (LTFU) patients in 4 rural and urban Zambian districts. We developed a phlebotomy box to transport DBS without contamination at ambient temperature and concomitant training and standard operating procedures. We evaluated this through field observations, bi-weekly meetings, reports, and staff meetings. The laboratory assessed DBS quality for testing validity. We attempted to collect DBS from 357 participants in the community. Though individual reasons for refusal from the remaining 37% were not collected, NMPs reported privacy concerns, awkward box-size which drew attention in the community and fears of undisclosed uses of samples related to witchcraft and circulating narratives about past research. Successful DBS collection was not associated with patient gender, age, time on ART, enrolment CD4, facility. DBS viral-load collection by NMP is feasible in Zambia. Our training approach and assessments of NMP not part of the health system can be extended to patients by giving them more responsibility to manage their own differentiated care groups. Concerted efforts that compare collection of DBS by NMP to those collected by skilled-medical personnel are needed.

6 August 2016 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
MVMichael J. Vinikoor
Michael J. Vinikoor
LMLloyd Mulenga
Lloyd Mulenga
ASAlice Siyunda
Alice Siyunda
KMKalo Musukuma-Chifulo
Kalo Musukuma-Chifulo
RCRoma Chilengi
Roma Chilengi
I(International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA‐SA)
International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA‐SA)
Objective To describe liver disease epidemiology among HIV‐infected individuals in Zambia. Methods We recruited HIV‐infected adults (≥18 years) at antiretroviral therapy initiation at two facilities in Lusaka. Using vibration controlled transient elastography, we assessed liver stiffness, a surrogate for fibrosis/cirrhosis, and analysed liver stiffness measurements (LSM) according to established thresholds (>7.0 kPa for significant fibrosis and >11.0 kPa for cirrhosis). All participants underwent standardised screening for potential causes of liver disease including chronic hepatitis B (HBV) and C virus co‐infection, herbal medicine, and alcohol use. We used multivariable logistic regression to identify factors associated with elevated liver stiffness. Results Among 798 HIV‐infected patients, 651 had a valid LSM (median age, 34 years; 53% female). HBV co‐infection (12%) and alcohol use disorders (41%) were common and hepatitis C virus co‐infection (7.0 kPa (all P < 0.05). HBV co‐infection was the only independent risk factor for LSM >11.0 kPa. Among HIV–HBV patients, those with elevated ALT and HBV viral load were more likely to have significant liver fibrosis than patients with normal markers of HBV activity. Conclusions HBV co‐infection was the most important risk factor for liver fibrosis and cirrhosis and should be diagnosed early in HIV care to optimise treatment outcomes.

17 March 2015 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
MVM. J. Vinikoor
M. J. Vinikoor
KMKalo Musukuma-Chifulo
Kalo Musukuma-Chifulo
VMV. Munamunungu
V. Munamunungu
MMM. Masaninga
M. Masaninga
ISI. Sikazwe
I. Sikazwe
GWG. Wandeler
G. Wandeler